Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, Eric Vermetten, Robert A Schoevers
CNS Drugs August 17, 2020 DOI: 10.1007/s40263-020-00748-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Qualitative Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychedelic treatment Entheogenic medicine Psychedelic healing Psychedelic interventions Mental health Mental disorders Psychological well-being Emotional health Psychiatric conditions Mental illness relief Therapeutic outcomes Clinical improvements Treatment benefits Psychological shifts Personal growth Therapeutic effects Patient insights Emotional processing Connectedness |
| Citations | 217 |
| Key findings | Qualitative research on psychedelic treatments can distinguish specific features of different substances and reveal undiscovered implications for treating specific psychiatric disorders. |
Abstract
This review demonstrates how qualitative research of psychedelic treatments can contribute to distinguishing specific features of specific substances, and carry otherwise undiscovered implications for the treatment of specific psychiatric disorders.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 177
- Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 2023
- Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression Frontiers in Pharmacology March 31, 2022
- Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review. Current Neuropharmacology 2024
- Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review Journal of Psychopharmacology August 26, 2022
- Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature Brain Sciences June 27, 2021
and 172 more in the library
Cites 87
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 82 more in the library